Search PubMed⌕ Search

SEARCH · Search PubMed

Results for “MONSTERS”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 55 records · Page 3Linked to original sources

Case of dermatofibroma with monster cells: a review and an immunohistochemical study.

We report a dermatofibroma with monster cells. The patient was a 79-year-old woman who had a dark-brown nodule of her left leg for approximately 3 years. The lesion was composed of spindle-shaped fibroblastic cells, histiocytic cells, and multinucleated giant cells. Most of the histiocytic cells had foamy cytoplasm with numerous hemosiderin deposits. In addition to these cells, bizarre multinucleated cells with markedly hyperchromatic nuclei and xanthomatous cells with very large nuclei (monster cells) were also noted. No mitotic figures of the cellular components were present. This lesion has been shown to be completely benign despite the presence of pleomorphic or bizarre cells. From a clinical standpoint, recognition of a benign lesion of this type is very important since an incorrect histologic interpretation could result in inappropriate treatment.

Aged↗

Photosensitive seizures provoked while viewing "pocket monsters," a made-for-television animation program in Japan.

PURPOSE: To describe the recent epidemic of photosensitive seizure that occurred in relation to an episode of the television animation program "Pocket Monsters," we report four patients who experienced seizures while watching the episode in question. We also report some technical aspects of the program episode. METHODS: We investigated the clinical symptoms of the four patients and performed routine EEGs with intermittent photic stimulation (IPS). If IPS provoked no photoparoxysmal response (PPR) during the routine EEG examination, a second EEG was performed with the photic stimulator placed 10 cm from the patient's eyes. In addition, we reviewed the "Pocket Monsters" episode, focusing our attention on the visual techniques used with reference to the Independent Television Commission (ITC) guidelines. RESULTS: One patient who had myoclonic jerks before the convulsion in question was diagnosed as having juvenile myoclonic epilepsy, and the diagnosis of another patient was pure photosensitive epilepsy. The remaining two patients had their first seizures, which could be occasional seizures, and we therefore could not reach a diagnosis of epilepsy. In our four patients, only one showed PPR on the routine EEG. Two patients revealed PPR on the second EEG, and the remaining patient showed no PPR. Rapid changes in color are believed to be responsible for the photosensitive seizures because all four patients had seizures at around 18:50, when seconds of deep red and bright blue flashes, alternating at a frequency of 12 Hz, were shown. CONCLUSIONS: Regulations for technical aspects of children's programming, including the use of colors, are urgently needed in Japan to prevent a repeated incident. In addition, the IPS procedure needs to be standardized, especially for patients who are suspected to have photosensitivity.

Adolescent↗

[Fetus in fetu and acardiac monster: can the similar patterns of these 2 malformations be explained by a common morphogenic mechanism?].

Fetus in fetu and acardiac monster are two unusual malformations (estimated incidences: 1 in 500,000 and 1 in 34,600 deliveries respectively) which present very similar morphological patterns. The authors report two cases of acardiac monster and a case of fetus in fetu which emphasize this fact. These findings suggest that a single morphogenic mechanism leads to the defects observed in these two groups of malformations.

Abnormalities, Severe Teratoid↗

[Anatomic study of a omphalosite monster].

The authors report the main anatomical features of a twin holoacardius amorphus monster. Diagnosis of the abnormality was assured by echography at the end of a "normal" gemellary pregnancy. Echograms were consistent with the diagnosis of "amorphus monster" and this was supported by dissection. The caudal extremity of the fetus was clearly identified by the presence of recognizable lower limbs in spite of the several abnormalities of the pelvic area. The cephalic extremity was characteristic of the malformation. Examinations of visceres allowed to precisely identify digestive structures such as intestinal loops (with disseminated atresias). It could not be find any kidney structure. Medially, a small rounded mass was observed and could be identified as hypoplasic cardiac structure. Other main anatomic features consisted of an enormous liquid-filled cavity largely communicating with both the lower part of the neural tube and the basis of the cranium. The placenta was unique and two umbilical with several and large anastomotic by-passes were increased from it.

Abnormalities, Multiple↗

Conjoined acardiac monsters.

The first known case of conjoined acardiac monsters in a twin pregnancy is reported. The conjoined monsters shared a single abdominal-thoracic artery and a primitive single-chambered heart. The placenta was monoamniotic with two umbilical cords. A classification of acardia as well as a discussion of possible mechanisms leading to the development of this anomaly are presented.

Abnormalities, Severe Teratoid↗

A "FRankenstein's monster" approach to comparative modeling: merging the finest fragments of Fold-Recognition models and iterative model refinement aided by 3D structure evaluation.

We applied a new multi-step protocol to predict the structures of all targets during CASP5, regardless of their potential category. 1) We used diverse fold-recognition (FR) methods to generate initial target-template alignments, which were converted into preliminary full-atom models by comparative modeling. All preliminary models were evaluated (scored) by VERIFY3D to identify well- and poorly-folded fragments. 2) Preliminary models with similar 3D folds were superimposed, poorly-scoring regions were deleted and the "average model" structure was created by merging the remaining segments. All template structures reported by FR were superimposed and a composite multiple-structure template was created from the most conserved fragments. 3). The average model was superimposed onto the composite template and the structure-based target-template alignment was inferred. This alignment was used to build a new (intermediate) comparative model of the target, again scored with VERIFY3D. 4) For all poorly scoring regions series of alternative alignments were generated by progressively shifting the "unfit" sequence fragment in either direction. Here, we considered additional information, such as secondary structure, placement of insertions and deletions in loops, conservation of putative catalytic residues, and the necessity to obtain a compact, well-folded structure. For all alternative alignments, new models were built and evaluated. 5) All models were superimposed and the "FRankenstein's monster" (FR, fold recognition) model was built from best-scoring segments. The final model was obtained after limited energy minimization to remove steric clashes between sidechains from different fragments. The novelty of this approach is in the focus on "vertical" recombination of structure fragments, typical for the ab initio field, rather than "horizontal" sequence alignment typical for comparative modeling. We tested the usefulness of the "FRankenstein" approach for non-expert predictors: only the leader of our team had considerable experience in protein modeling - he registered as a separate group (020) and submitted models built only by himself. At the onset of CASP5, the other five members of the team (students) had very little or no experience with modeling. They followed the same protocol in a deliberately naïve way. In the fourth step they used solely the VERIFY3D criterion to compare their models and the leader's model (the latter regarded only as one of the many alternatives) and generated the hybrid or selected only one model for submission (group 517). In order to compare our protocol with the traditional "one target-one template-one alignment" approach, we submitted (as a separate group 242) models selected from those automatically generated by all CAFASP servers (i.e. obtained without any human intervention). Here, we compare the results obtained by the three "groups", describe successes and failures of the "FRankenstein" approach and discuss future developments of comparative modeling. The automatic version of our multi-step protocol is being developed as a meta-server; the prototype is freely available at http://genesilico.pl/meta/.

Algorithms↗

A note on the epidemiology of acardiac monsters.

The literature on acardiac monsters has been reviewed. The following conclusions were drawn: 1. The probability of their appearance seems considerably higher among monoamniotic than diamniotic monochorionic twin pairs. 2. They seem more likely to occur within monozygotic (MZ) pairs in higher multiple births than in MZ twins. 3. The data are consistent with the suggestion that there is a slight female excess among them.

Abnormalities, Severe Teratoid↗

The acardiac monster.

Two cases of acardiac fetuses are presented. Pathological data in 61 cases are tabulated. Cliassification, terminology and patho-physiological findings are discussed. The Acardiac Monster is a form of monozygotic multiple gestation lacking a physiological heart and resulting in a bizarre fetal malformation which is sustained in utero by parasitic anastomoses to the circulation of a normal twin fetus. The precise etiology of this phenomenon is still obscure and suggestions are made for the future evaluation of the acardiac fetus.

Abnormalities, Severe Teratoid↗

Effects of VIP and related peptides and Gila monster venom on genitourinary smooth muscle.

The pharmacological effects of peptide histidine isoleucine (PHI), glucagon and secretin were compared with vasoactive intestinal polypeptide (VIP) on rabbit urethra and anococcygeus muscle. VIP and PHI dose-dependently inhibited induced contractions of both smooth muscle preparations. Cross-tachyphylaxis between VIP and PHI was demonstrated in the urethra preparation, suggesting that their activity is mediated via a common receptor or second messenger. Glucagon and secretin were without effect on either preparation. Radioimmunoassays demonstrated substantial concentrations of VIP and PHI in both urethra and anococcygeus tissue extracts. These observations suggest that PHI is an additional candidate together with VIP to mediate relaxation of rabbit urethra and anococcygeus muscle. When compared with VIP, Gila monster venom was found to inhibit both smooth muscle preparations, producing concentration-response curves parallel to those produced by VIP.

Animals↗

Purification of a novel pancreatic secretory factor (PSF) and a novel peptide with VIP- and secretin-like properties (helodermin) from Gila monster venom.

A combination of three HPLC procedures applied to the venom of Gila monster (Heloderma suspectum) has led to the purification to homogeneity of two bioactive components: (i) a 17.5 kDa protein, isolated on the basis of its potent secretory effect on dispersed rat pancreatic acini, was accordingly designated PSF (pancreatic secretory factor); (ii) a 5.9-kDa peptide, designated helodermin, was purified on the basis of its ability to stimulate adenylate cyclase in rat pancreatic membranes. PSF was unable to activate adenylate cyclase and, conversely, helodermin was devoid of secretory action.

Adenylyl Cyclases↗

Evidence that helodermin, a newly extracted peptide from Gila monster venom, is a member of the secretin/VIP/PHI family of peptides with an original pattern of biological properties.

Helodermin, a newly isolated peptide from the venom of Gila monster (Heloderma suspectum) was shown to stimulate the adenylate cyclase activity of rat pancreatic membranes as efficiently as secretin and VIP. It also increased cyclic AMP levels and inhibited [125I]VIP binding in rat pancreatic acini. Finally, helodermin activated adenylate cyclase in membranes from rat heart, rat brain, and human heart, showing properties analogous yet distinct from those of secretin, VIP and PHI.

Adenylyl Cyclases↗

Pancreatic secretory factor (PSF), a protein from Gila monster venom stimulating enzyme secretion from rat pancreatic acini.

Pancreatic secretory factor (PSF), a 17.5-kDa protein purified from the venom of Gila monster (Heloderma suspectum), stimulated amylase secretion from dispersed rat pancreatic acini more efficiently than CCK-8, bombesin, carbachol and secretin, and without increasing 45Ca2+ efflux and cyclic AMP levels. The secretory action was dependent on the presence of extracellular calcium and was additive to the secretion induced by agents acting via cyclic AMP or via Ca2+ efflux.

Amylases↗

Primary structure of helodermin, a VIP-secretin-like peptide isolated from Gila monster venom.

The complete amino acid sequence of helodermin isolated from the venom of Gila monster was elucidated. The peptide was shown to be a basic pentatriacontapeptide amide: His-Ser-Asp-Ala-Ile-Phe-Thr-Gln-Gln-Tyr-Ser-Lys-Leu-Leu-Ala-Lys-Leu-Ala- Leu-Gln-Lys- Tyr-Leu-Ala-Ser-Ile-Leu-Gly-Ser-Arg-Thr-Ser-Pro-Pro-Pro-NH2. A high degree of sequence similarities to secretin/VIP/PHI/(PHM)/GRF from mammal and bird was observed over the entire N-terminal 1-27 sequence. In particular, the amino acid residues in positions 3, 6 and 7 were found to be common to 9 peptides of the family. Another interesting feature of the structure of helodermin was its C-terminal -Pro-Pro-Pro-NH2 sequence. Isolation of helodermin was the first demonstration of the existence of a secretin/VIP-related peptide in an animal that is neither mammal nor bird.

Amino Acid Sequence↗

An equine fetal monster dicephalus tetrapus dibrachius.

Double monsters are structurally related to monozygotic twins and the reported frequency of these abnormalities in the equine species is low. Symmetrical, double development in both the cephalic region and caudal trunk was demonstrated along with a common undeveloped cervical mass. Anomalies found in the separate genito-urinary systems added another variant to this case.

Journal Article↗

Hypotension, myocardial infarction, and coagulopathy following gila monster bite.

We report a 23-year-old man who developed life threatening hypotension, myocardial infarction, coagulopathy, and renal failure following the bite of a Gila monster (Heloderma suspectum). These are previously unreported complications in humans. The patient recovered after fluid resuscitation and treatment with pressor agents.

Acute Kidney Injury↗

Isolation and cloning of exendin precursor cDNAs from single samples of venom from the Mexican beaded lizard (Heloderma horridum) and the Gila monster (Heloderma suspectum).

Reptile venoms are complex cocktails of bioactive molecules, including peptides. While the drug discovery potential of most species remains unrealized, many are endangered and afforded protection under international treaties. In this study, we describe how potential clinically important bioactive peptides and their corresponding mRNAs can be structurally characterized from single, small samples of reptile venom. The potential type-2 diabetes therapeutics, exendin-3 and exendin-4, from the Mexican beaded lizard (Heloderma horridum) and the Gila monster (Heloderma suspectum), respectively, have been characterized at both protein and nucleic acid levels to illustrate the efficacy of the technique and its contribution to biodiversity conservation.

Animals↗

Life-threatening anaphylaxis following gila monster bite.

We report the case of a 40-year-old man who developed life-threatening angioedema and hypotension following the bite of a Gila monster (Heloderma suspectum), a venomous lizard of the southwestern United States. He recovered after treatment with IV fluids, epinephrine, antihistamines, and corticosteroids.

Adult↗

Hopeful monsters and morphogens at the beach.

The Santa Cruz Developmental Biology Conference (August 15-19, 2002) provided the latest insights into how a single cell is transformed into a complex organism. Organisms that flower, slither, walk and fly continue to provide new insights into the cell biological and molecular mechanisms that control cell movement, signalling pathways and post-transcriptional regulation; hopeful monsters sit at our doorstep to provide new insight into evolutionary change and human disease.

Animals↗